Literature DB >> 23164073

Prevalence of otomycosis in Khouzestan Province, south-west Iran.

N Saki1, A Rafiei, S Nikakhlagh, N Amirrajab, S Saki.   

Abstract

BACKGROUND: This study aimed to investigate the prevalence of otomycosis and aetiological agents in Khouzestan province, south-west Iran.
METHODS: This cross-sectional study examined and cultured 881 swabs from suspected external otitis cases, collected from throughout Khouzestan province. Fungal agents were identified by slide culture and complementary tests when necessary.
RESULTS: The mean patient age was 37 years. The 20-39 year age group had the highest prevalence of otomycosis: 293 cases, comprising 162 (55.3 per cent) women and 131 (44.7 per cent) men. The seasonal distribution of cases was: summer, 44.7 per cent; autumn, 28.7 per cent; winter, 14.7 per cent; and spring, 11.9 per cent. The fungal agents isolated were Aspergillus niger (67.2 per cent), Aspergillus flavus (13 per cent), Candida albicans (11.6 per cent), Aspergillus fumigatus (6.2 per cent) and penicillium species (2 per cent).
CONCLUSION: Fungal otomycosis is still one of the most important external ear diseases. In this study in south-west Iran, Aspergillus niger was the predominant aetiological agent. However, clinicians should be cautious of candidal otomycosis, which has a lower rate of incidence but is more prevalent among 20-39 year olds.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23164073     DOI: 10.1017/S0022215112002277

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  9 in total

Review 1.  Otomycosis in iran: a review.

Authors:  Maral Gharaghani; Zahra Seifi; Ali Zarei Mahmoudabadi
Journal:  Mycopathologia       Date:  2015-01-30       Impact factor: 2.574

Review 2.  Otomycosis in the South of Iran with a High Prevalence of Tympanic Membrane Perforation: A Hospital-Based Study.

Authors:  Javad Javidnia; Zahra Ghotbi; Aynaz Ghojoghi; Kavous Solhjoo; Mohamed Mahdi Alshahni; Seyed Ali Jeddi; Bahram Ahmadi; Sadegh Nouripour-Sisakht; Saham Ansari; Gholamreza Shokoohi
Journal:  Mycopathologia       Date:  2022-03-26       Impact factor: 2.574

3.  Otomycosis in Adolescent Patients Referred to the Therapeutic Centers in Babol City, Iran.

Authors:  Keivan Kiakojuri; Ramazan Rajabnia; Bahareh Jalili; Soraya Khafri; Saeid Mahdavi Omran
Journal:  Jundishapur J Microbiol       Date:  2015-05-31       Impact factor: 0.747

4.  Lamisil, a potent alternative antifungal drug for otomycosis.

Authors:  A Zarei Mahmoudabadi; Z Seifi; M Gharaghani
Journal:  Curr Med Mycol       Date:  2015-03

5.  Otomycosis in Damascus, Syria: Etiology and clinical features.

Authors:  Mohammad T Ismail; Abeer Al-Kafri; Mazen Ismail
Journal:  Curr Med Mycol       Date:  2017-09

6.  Investigation of Etiologic Agents and Clinical Presentations of Otomycosis at a Tertiary Referral Center in Tehran, Iran.

Authors:  Hasti Kamali Sarwestani; Roshanak Daie Ghazvini; Seyed Jamal Hashemi; Sassan Rezaie; Mohsen Gerami Shoar; Shahram Mahmoudi; Miad Elahi; Ardavan Tajdini
Journal:  Iran J Public Health       Date:  2019-02       Impact factor: 1.429

7.  A search for new otomycotic species and their sensitivity to different antifungals.

Authors:  Mohammed Rifaat Ahmed; Ashraf Saad Abou-Halawa; Waheed F Hessam; Diaa' Salaheldin Aly Abdelkader
Journal:  Interv Med Appl Sci       Date:  2018-09

8.  Effect of combination therapy with ceftizoxime and clotrimazole in the treatment of otomycosis.

Authors:  Saeid Mahdavi Omran; Zahra Yousefzade; Soraya Khafri; Mojtaba Taghizadeh-Armaki; Keyvan Kiakojuri
Journal:  Curr Med Mycol       Date:  2018-03

9.  Role of Clotrimazole in Prevention of Recurrent Otomycosis.

Authors:  Keyvan Kiakojuri; Ramazan Rajabnia; Saeid Mahdavi Omran; Abazar Pournajaf; Mohsen Karami; Mojtaba Taghizadeh Armaki
Journal:  Biomed Res Int       Date:  2019-12-26       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.